QA: Onconetix Inc in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001782107_2025_Onconetix_Inc.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001782107, Onconetix Inc

  xvar xval
0 AssetsCurrent 950,267
1 IntangibleAssetsNetIncludingGoodwill 27,048,973
2 PropertyPlantAndEquipmentNet 62,896
3 remainder_Assets 119,427
4 LiabilitiesCurrent 18,290,129
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 280,879
7 CostOfGoodsAndServicesSold 1,469,018
8 SellingGeneralAndAdministrativeExpense 11,231,982
9 ResearchAndDevelopmentExpense 154,359
10 remainder_Expenses 45,112,332
11 remainder_Revenues 2,524,116
12 remainder_NetIncome -3,247,448
13 remainder_ComprehensiveNetIncome -5,104,317
  yvar yval
0 Assets 28,181,563
1 Liabilities 18,571,008
2 Expenses 57,967,691
3 Revenues 2,524,116
4 StockholdersEquity 9,610,555
5 NetIncome -58,691,023
6 ComprehensiveNetIncome -61,243,182
7 BaseVar 57,798,072
8 EconomicCapitalRatiobeforeLimitedLiability -1.72
9 EconomicCapitalRatio 1.11

Edgar->Model Mapping

Feature Distribution

Change over Time